NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV
Delisted
NBRV was delisted on the 31st of July, 2023.
50 hedge funds and large institutions have $37.3M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding
Funds holding: 44 → 50 (+6)
20% less capital invested
Capital invested by funds: $46.6M → $37.3M (-$9.3M)
Holders
50
Holding in Top 10
2
Calls
$103K
Puts
$82K
Top Buyers
| 1 | +$4.58M | |
| 2 | +$1.55M | |
| 3 | +$1.37M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$271K |
| 5 |
CPP
Crow Point Partners
Boston,
Massachusetts
|
+$143K |
Top Sellers
| 1 | -$886K | |
| 2 | -$666K | |
| 3 | -$395K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$363K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$264K |